| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 82 | 2023 | 332 | 20.230 |
Why?
|
| Alcohol Drinking | 56 | 2023 | 361 | 11.790 |
Why?
|
| Veterans | 51 | 2022 | 137 | 11.630 |
Why?
|
| Primary Health Care | 48 | 2023 | 756 | 7.790 |
Why?
|
| Mass Screening | 42 | 2022 | 667 | 7.240 |
Why?
|
| United States Department of Veterans Affairs | 41 | 2022 | 120 | 6.410 |
Why?
|
| Alcohol-Related Disorders | 15 | 2022 | 46 | 5.170 |
Why?
|
| Opioid-Related Disorders | 11 | 2023 | 165 | 4.580 |
Why?
|
| Surveys and Questionnaires | 49 | 2019 | 1322 | 4.040 |
Why?
|
| Humans | 168 | 2023 | 17707 | 3.830 |
Why?
|
| Middle Aged | 110 | 2022 | 7976 | 3.680 |
Why?
|
| United States | 80 | 2022 | 3914 | 3.560 |
Why?
|
| Substance-Related Disorders | 15 | 2022 | 420 | 3.500 |
Why?
|
| Male | 120 | 2023 | 10094 | 3.390 |
Why?
|
| Aged | 84 | 2022 | 6150 | 3.260 |
Why?
|
| Adult | 88 | 2022 | 7658 | 2.950 |
Why?
|
| Female | 112 | 2023 | 12729 | 2.870 |
Why?
|
| HIV Infections | 7 | 2021 | 704 | 2.200 |
Why?
|
| Hospitalization | 18 | 2023 | 805 | 2.170 |
Why?
|
| Buprenorphine | 4 | 2021 | 44 | 2.070 |
Why?
|
| Counseling | 9 | 2017 | 187 | 1.960 |
Why?
|
| Marijuana Abuse | 3 | 2022 | 39 | 1.950 |
Why?
|
| Cross-Sectional Studies | 31 | 2022 | 1322 | 1.860 |
Why?
|
| Electronic Health Records | 7 | 2022 | 694 | 1.860 |
Why?
|
| Substance Abuse Detection | 4 | 2020 | 17 | 1.790 |
Why?
|
| Psychotherapy, Brief | 5 | 2017 | 20 | 1.760 |
Why?
|
| Ambulatory Care | 10 | 2020 | 241 | 1.730 |
Why?
|
| Prevalence | 25 | 2021 | 882 | 1.670 |
Why?
|
| Postoperative Complications | 5 | 2022 | 103 | 1.530 |
Why?
|
| Patient-Centered Care | 3 | 2018 | 194 | 1.490 |
Why?
|
| Young Adult | 29 | 2020 | 2450 | 1.480 |
Why?
|
| Opiate Substitution Treatment | 5 | 2021 | 42 | 1.370 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 1927 | 1.350 |
Why?
|
| Outpatients | 9 | 2019 | 107 | 1.340 |
Why?
|
| Mental Disorders | 9 | 2020 | 276 | 1.230 |
Why?
|
| Reminder Systems | 4 | 2015 | 80 | 1.190 |
Why?
|
| Hospitals, Veterans | 11 | 2012 | 32 | 1.160 |
Why?
|
| Quality of Health Care | 4 | 2015 | 276 | 1.150 |
Why?
|
| Retrospective Studies | 23 | 2023 | 2471 | 1.140 |
Why?
|
| Medical Marijuana | 3 | 2022 | 23 | 1.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2013 | 59 | 1.130 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 397 | 1.100 |
Why?
|
| Sex Factors | 9 | 2017 | 639 | 1.080 |
Why?
|
| Patient Readmission | 4 | 2017 | 164 | 1.080 |
Why?
|
| Cohort Studies | 21 | 2021 | 2589 | 1.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2022 | 26 | 0.980 |
Why?
|
| Smoking | 6 | 2017 | 483 | 0.980 |
Why?
|
| Emergency Service, Hospital | 6 | 2020 | 377 | 0.980 |
Why?
|
| Self Report | 5 | 2022 | 252 | 0.960 |
Why?
|
| Medication Adherence | 3 | 2021 | 245 | 0.920 |
Why?
|
| Bariatric Surgery | 3 | 2022 | 128 | 0.920 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2021 | 22 | 0.920 |
Why?
|
| Cannabis | 3 | 2022 | 81 | 0.910 |
Why?
|
| Adolescent | 23 | 2022 | 3671 | 0.890 |
Why?
|
| Wounds and Injuries | 3 | 2016 | 46 | 0.870 |
Why?
|
| Health Care Surveys | 3 | 2022 | 223 | 0.850 |
Why?
|
| Insurance | 1 | 2022 | 5 | 0.830 |
Why?
|
| Veterans Health | 5 | 2022 | 16 | 0.820 |
Why?
|
| Documentation | 4 | 2022 | 42 | 0.810 |
Why?
|
| Age Factors | 13 | 2019 | 918 | 0.800 |
Why?
|
| Quality Indicators, Health Care | 2 | 2013 | 142 | 0.740 |
Why?
|
| Patient Discharge | 2 | 2015 | 153 | 0.740 |
Why?
|
| Obesity | 3 | 2022 | 841 | 0.740 |
Why?
|
| Attitude of Health Personnel | 7 | 2018 | 211 | 0.730 |
Why?
|
| Risk Factors | 23 | 2015 | 3367 | 0.730 |
Why?
|
| Health Surveys | 7 | 2017 | 260 | 0.720 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2021 | 12 | 0.720 |
Why?
|
| Anti-Retroviral Agents | 2 | 2021 | 80 | 0.710 |
Why?
|
| Marijuana Smoking | 2 | 2019 | 51 | 0.700 |
Why?
|
| Cholesterol, HDL | 3 | 2019 | 81 | 0.700 |
Why?
|
| Bias | 3 | 2020 | 103 | 0.690 |
Why?
|
| Logistic Models | 12 | 2017 | 918 | 0.690 |
Why?
|
| Hepatitis C | 1 | 2021 | 64 | 0.680 |
Why?
|
| Soft Tissue Infections | 4 | 2009 | 10 | 0.670 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2009 | 33 | 0.660 |
Why?
|
| Analgesics, Opioid | 7 | 2023 | 243 | 0.650 |
Why?
|
| Behavior, Addictive | 1 | 2019 | 12 | 0.630 |
Why?
|
| Ambulatory Care Facilities | 2 | 2018 | 67 | 0.620 |
Why?
|
| Aging | 2 | 2018 | 163 | 0.610 |
Why?
|
| Program Evaluation | 2 | 2020 | 222 | 0.610 |
Why?
|
| Washington | 12 | 2020 | 382 | 0.610 |
Why?
|
| Treatment Outcome | 10 | 2022 | 1254 | 0.600 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2017 | 227 | 0.600 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 123 | 0.590 |
Why?
|
| Evidence-Based Medicine | 4 | 2019 | 179 | 0.590 |
Why?
|
| Internal Medicine | 5 | 2006 | 20 | 0.590 |
Why?
|
| Time Factors | 9 | 2020 | 1095 | 0.580 |
Why?
|
| Iraq War, 2003-2011 | 4 | 2016 | 8 | 0.580 |
Why?
|
| Intensive Care Units | 2 | 2016 | 103 | 0.560 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2020 | 54 | 0.550 |
Why?
|
| Aftercare | 2 | 2016 | 48 | 0.540 |
Why?
|
| Health Expenditures | 1 | 2017 | 70 | 0.530 |
Why?
|
| Psychometrics | 4 | 2014 | 122 | 0.530 |
Why?
|
| Mitochondria | 2 | 2016 | 4 | 0.520 |
Why?
|
| Health Status | 6 | 2016 | 299 | 0.520 |
Why?
|
| Cerebrospinal Fluid | 1 | 2016 | 2 | 0.510 |
Why?
|
| Cerebral Ventricles | 1 | 2016 | 2 | 0.510 |
Why?
|
| Sensitivity and Specificity | 7 | 2020 | 304 | 0.510 |
Why?
|
| Women's Health | 4 | 2006 | 199 | 0.510 |
Why?
|
| Ethanol | 1 | 2016 | 22 | 0.510 |
Why?
|
| Lactic Acid | 1 | 2016 | 11 | 0.510 |
Why?
|
| Mental Health Services | 3 | 2013 | 154 | 0.510 |
Why?
|
| Motivation | 3 | 2006 | 130 | 0.510 |
Why?
|
| Patient Compliance | 4 | 2014 | 299 | 0.500 |
Why?
|
| Physician-Patient Relations | 5 | 2006 | 185 | 0.500 |
Why?
|
| Referral and Consultation | 5 | 2017 | 165 | 0.490 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 531 | 0.490 |
Why?
|
| Critical Care | 1 | 2016 | 70 | 0.480 |
Why?
|
| Health Behavior | 4 | 2014 | 360 | 0.480 |
Why?
|
| Data Accuracy | 1 | 2015 | 27 | 0.470 |
Why?
|
| Physicians, Primary Care | 2 | 2018 | 71 | 0.470 |
Why?
|
| Diabetes Mellitus | 2 | 2012 | 483 | 0.470 |
Why?
|
| Self Care | 2 | 2014 | 164 | 0.470 |
Why?
|
| Pilot Projects | 4 | 2019 | 215 | 0.470 |
Why?
|
| Disease Management | 1 | 2015 | 136 | 0.460 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2014 | 24 | 0.460 |
Why?
|
| Reproducibility of Results | 8 | 2016 | 371 | 0.450 |
Why?
|
| Women | 3 | 2016 | 12 | 0.450 |
Why?
|
| Depression | 7 | 2022 | 504 | 0.450 |
Why?
|
| Internet | 2 | 2014 | 229 | 0.450 |
Why?
|
| Self Disclosure | 1 | 2014 | 22 | 0.440 |
Why?
|
| Weight Loss | 3 | 2020 | 305 | 0.440 |
Why?
|
| Mortality | 3 | 2010 | 118 | 0.430 |
Why?
|
| Alcoholic Beverages | 1 | 2013 | 14 | 0.420 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 1218 | 0.420 |
Why?
|
| Internship and Residency | 3 | 2006 | 46 | 0.420 |
Why?
|
| Inpatients | 3 | 2021 | 81 | 0.420 |
Why?
|
| Hypertension | 3 | 2014 | 498 | 0.410 |
Why?
|
| General Surgery | 1 | 2012 | 2 | 0.400 |
Why?
|
| Socioeconomic Factors | 6 | 2017 | 626 | 0.380 |
Why?
|
| Fractures, Bone | 2 | 2012 | 95 | 0.380 |
Why?
|
| Postoperative Care | 1 | 2012 | 20 | 0.380 |
Why?
|
| Directive Counseling | 2 | 2010 | 25 | 0.360 |
Why?
|
| Smoking Cessation | 2 | 2012 | 193 | 0.360 |
Why?
|
| Qualitative Research | 5 | 2022 | 257 | 0.360 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2012 | 196 | 0.350 |
Why?
|
| Health Services | 1 | 2011 | 114 | 0.350 |
Why?
|
| Regression Analysis | 6 | 2019 | 296 | 0.350 |
Why?
|
| Physician's Role | 1 | 2010 | 30 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 327 | 0.340 |
Why?
|
| Gulf War | 1 | 2010 | 2 | 0.340 |
Why?
|
| Electronic Mail | 1 | 2010 | 51 | 0.340 |
Why?
|
| Risk-Taking | 3 | 2007 | 107 | 0.330 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 448 | 0.320 |
Why?
|
| Exercise | 1 | 2014 | 496 | 0.320 |
Why?
|
| Family Practice | 4 | 2004 | 43 | 0.310 |
Why?
|
| Ethnic Groups | 5 | 2020 | 474 | 0.310 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2013 | 387 | 0.310 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 717 | 0.300 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 2011 | 3 | 0.300 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2011 | 5 | 0.300 |
Why?
|
| Behavior Therapy | 2 | 2023 | 144 | 0.300 |
Why?
|
| Research Design | 2 | 2021 | 372 | 0.300 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 85 | 0.280 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2007 | 20 | 0.270 |
Why?
|
| Health Care Costs | 1 | 2009 | 222 | 0.270 |
Why?
|
| Practice (Psychology) | 1 | 2006 | 1 | 0.270 |
Why?
|
| Papanicolaou Test | 1 | 2006 | 37 | 0.270 |
Why?
|
| Vaginal Smears | 1 | 2006 | 48 | 0.260 |
Why?
|
| Prospective Studies | 7 | 2012 | 1287 | 0.260 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 37 | 0.260 |
Why?
|
| Social Environment | 1 | 2007 | 87 | 0.260 |
Why?
|
| European Continental Ancestry Group | 4 | 2012 | 523 | 0.260 |
Why?
|
| Surgical Procedures, Operative | 1 | 2006 | 16 | 0.260 |
Why?
|
| Binge Drinking | 2 | 2016 | 8 | 0.260 |
Why?
|
| Television | 1 | 2006 | 22 | 0.260 |
Why?
|
| Clinical Competence | 1 | 2006 | 95 | 0.260 |
Why?
|
| Eating | 1 | 2006 | 37 | 0.250 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 74 | 0.250 |
Why?
|
| Medical Audit | 3 | 2016 | 35 | 0.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2017 | 381 | 0.250 |
Why?
|
| Risk Assessment | 4 | 2012 | 1106 | 0.250 |
Why?
|
| Biomarkers | 3 | 2017 | 312 | 0.250 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2005 | 19 | 0.240 |
Why?
|
| Afghan Campaign 2001- | 3 | 2016 | 6 | 0.240 |
Why?
|
| Predictive Value of Tests | 5 | 2013 | 355 | 0.240 |
Why?
|
| Hysterectomy | 1 | 2005 | 28 | 0.240 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 54 | 0.240 |
Why?
|
| Comorbidity | 8 | 2016 | 590 | 0.240 |
Why?
|
| Hispanic Americans | 3 | 2012 | 397 | 0.230 |
Why?
|
| Chronic Disease | 3 | 2017 | 416 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 2 | 2016 | 27 | 0.220 |
Why?
|
| Length of Stay | 4 | 2012 | 182 | 0.220 |
Why?
|
| Laparoscopy | 2 | 2022 | 49 | 0.210 |
Why?
|
| Proportional Hazards Models | 5 | 2011 | 710 | 0.210 |
Why?
|
| Checklist | 2 | 2022 | 14 | 0.210 |
Why?
|
| Algorithms | 1 | 2005 | 237 | 0.210 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 12 | 0.210 |
Why?
|
| Confidence Intervals | 6 | 2010 | 237 | 0.210 |
Why?
|
| Gastric Bypass | 2 | 2022 | 71 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2017 | 311 | 0.200 |
Why?
|
| Interview, Psychological | 2 | 2014 | 19 | 0.200 |
Why?
|
| Preoperative Care | 3 | 2011 | 19 | 0.200 |
Why?
|
| Confidentiality | 1 | 2022 | 25 | 0.190 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 3 | 2013 | 26 | 0.190 |
Why?
|
| Medicaid | 1 | 2022 | 188 | 0.190 |
Why?
|
| African Continental Ancestry Group | 2 | 2012 | 162 | 0.180 |
Why?
|
| Nurse Administrators | 1 | 2021 | 6 | 0.180 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 6 | 0.180 |
Why?
|
| Natural Language Processing | 1 | 2022 | 58 | 0.180 |
Why?
|
| Employee Performance Appraisal | 1 | 2020 | 5 | 0.180 |
Why?
|
| Patient Participation | 2 | 2017 | 132 | 0.180 |
Why?
|
| Hallucinogens | 1 | 2021 | 22 | 0.180 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2000 | 8 | 0.180 |
Why?
|
| Down Syndrome | 1 | 2000 | 4 | 0.180 |
Why?
|
| Leadership | 1 | 2020 | 34 | 0.180 |
Why?
|
| Femur | 1 | 2000 | 10 | 0.180 |
Why?
|
| Benchmarking | 1 | 2020 | 40 | 0.170 |
Why?
|
| Odds Ratio | 5 | 2019 | 670 | 0.170 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2021 | 61 | 0.170 |
Why?
|
| Naltrexone | 1 | 2020 | 15 | 0.170 |
Why?
|
| Gestational Age | 1 | 2000 | 116 | 0.170 |
Why?
|
| Quality Improvement | 1 | 2021 | 189 | 0.170 |
Why?
|
| Cluster Analysis | 1 | 2020 | 90 | 0.160 |
Why?
|
| Mental Health | 2 | 2020 | 161 | 0.160 |
Why?
|
| Crisis Intervention | 1 | 2019 | 14 | 0.160 |
Why?
|
| Health Services Research | 1 | 2020 | 213 | 0.160 |
Why?
|
| Risk | 2 | 2011 | 517 | 0.160 |
Why?
|
| Adolescent Health | 1 | 2019 | 6 | 0.160 |
Why?
|
| Wine | 1 | 1999 | 18 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 34 | 0.160 |
Why?
|
| Decision Making | 2 | 2018 | 182 | 0.160 |
Why?
|
| Personality Assessment | 1 | 1998 | 15 | 0.160 |
Why?
|
| Personality Inventory | 1 | 1998 | 14 | 0.160 |
Why?
|
| Prescription Drug Monitoring Programs | 1 | 2018 | 1 | 0.150 |
Why?
|
| Heart Diseases | 1 | 1999 | 75 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 120 | 0.150 |
Why?
|
| Pharmacists | 1 | 2018 | 50 | 0.150 |
Why?
|
| ROC Curve | 5 | 2019 | 77 | 0.150 |
Why?
|
| Statistics as Topic | 2 | 2016 | 62 | 0.150 |
Why?
|
| Gyrus Cinguli | 1 | 2017 | 1 | 0.140 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 2 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 5 | 0.140 |
Why?
|
| Craving | 1 | 2017 | 11 | 0.140 |
Why?
|
| Atropine | 1 | 1997 | 1 | 0.140 |
Why?
|
| Albuterol | 1 | 1997 | 7 | 0.140 |
Why?
|
| Multivariate Analysis | 4 | 2010 | 561 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 1997 | 21 | 0.140 |
Why?
|
| Cholinergic Antagonists | 1 | 1997 | 6 | 0.140 |
Why?
|
| Asthma | 2 | 1997 | 385 | 0.140 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 33 | 0.140 |
Why?
|
| Motivational Interviewing | 1 | 2017 | 33 | 0.140 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 49 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 89 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 46 | 0.130 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 4 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2017 | 111 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2016 | 38 | 0.130 |
Why?
|
| Medicare | 1 | 2017 | 199 | 0.130 |
Why?
|
| Choline | 1 | 2016 | 1 | 0.130 |
Why?
|
| Aspartic Acid | 1 | 2016 | 2 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Creatine | 1 | 2016 | 4 | 0.130 |
Why?
|
| Heterosexuality | 1 | 2016 | 8 | 0.130 |
Why?
|
| Homosexuality, Female | 1 | 2016 | 7 | 0.130 |
Why?
|
| Anxiety | 1 | 2017 | 152 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 38 | 0.130 |
Why?
|
| Bisexuality | 1 | 2016 | 11 | 0.130 |
Why?
|
| Sexual and Gender Minorities | 1 | 2016 | 26 | 0.120 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2006 | 14 | 0.120 |
Why?
|
| Incidence | 3 | 2009 | 1269 | 0.120 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 131 | 0.120 |
Why?
|
| Allied Health Personnel | 1 | 2015 | 12 | 0.120 |
Why?
|
| Nurses | 1 | 2015 | 35 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2015 | 62 | 0.120 |
Why?
|
| Health Plan Implementation | 1 | 2015 | 36 | 0.120 |
Why?
|
| Tape Recording | 2 | 2006 | 6 | 0.120 |
Why?
|
| Warfarin | 1 | 2015 | 74 | 0.110 |
Why?
|
| Pain | 3 | 2020 | 79 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2015 | 128 | 0.110 |
Why?
|
| Contraception | 1 | 2014 | 25 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 3 | 2017 | 243 | 0.110 |
Why?
|
| Attitude to Health | 2 | 2005 | 159 | 0.110 |
Why?
|
| False Negative Reactions | 1 | 2013 | 12 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2013 | 26 | 0.110 |
Why?
|
| Chlorthalidone | 1 | 1993 | 1 | 0.110 |
Why?
|
| Probability | 1 | 2013 | 78 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 596 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2013 | 48 | 0.110 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 3 | 0.110 |
Why?
|
| Data Collection | 2 | 2010 | 252 | 0.110 |
Why?
|
| Quality of Life | 3 | 2016 | 521 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 40 | 0.110 |
Why?
|
| Cholesterol | 1 | 1993 | 106 | 0.100 |
Why?
|
| Cholesterol, LDL | 1 | 1993 | 119 | 0.100 |
Why?
|
| Feedback | 1 | 2012 | 19 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 42 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2002 | 324 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2012 | 16 | 0.100 |
Why?
|
| Reoperation | 1 | 2012 | 30 | 0.100 |
Why?
|
| Child | 3 | 2019 | 2481 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2004 | 212 | 0.090 |
Why?
|
| Pneumonia | 1 | 2012 | 51 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2012 | 69 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2013 | 220 | 0.090 |
Why?
|
| Geriatric Assessment | 2 | 2009 | 41 | 0.090 |
Why?
|
| Gastrectomy | 2 | 2022 | 46 | 0.090 |
Why?
|
| Educational Status | 3 | 2008 | 198 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2011 | 10 | 0.090 |
Why?
|
| African Americans | 2 | 2008 | 465 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2011 | 16 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2013 | 160 | 0.090 |
Why?
|
| Sexual Behavior | 2 | 2016 | 123 | 0.090 |
Why?
|
| Marital Status | 1 | 2009 | 20 | 0.080 |
Why?
|
| Education | 1 | 2009 | 16 | 0.080 |
Why?
|
| Reference Values | 2 | 2019 | 93 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2009 | 45 | 0.080 |
Why?
|
| Income | 1 | 2009 | 88 | 0.080 |
Why?
|
| Drug Users | 1 | 2009 | 7 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1117 | 0.080 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 85 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2008 | 84 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2010 | 63 | 0.080 |
Why?
|
| Continental Population Groups | 2 | 2006 | 301 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 159 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 123 | 0.070 |
Why?
|
| Practice Management, Medical | 1 | 2006 | 10 | 0.070 |
Why?
|
| Complementary Therapies | 1 | 2007 | 46 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2005 | 159 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 172 | 0.070 |
Why?
|
| Denial (Psychology) | 1 | 2006 | 1 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 271 | 0.060 |
Why?
|
| Breast Diseases | 1 | 2006 | 18 | 0.060 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2005 | 11 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2017 | 300 | 0.060 |
Why?
|
| Premenstrual Syndrome | 1 | 2005 | 2 | 0.060 |
Why?
|
| Military Personnel | 1 | 2005 | 12 | 0.060 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2005 | 19 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 100 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 166 | 0.060 |
Why?
|
| Reading | 1 | 2004 | 6 | 0.060 |
Why?
|
| Educational Measurement | 1 | 2004 | 18 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2004 | 44 | 0.060 |
Why?
|
| Pregnancy | 2 | 2000 | 1535 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2001 | 154 | 0.060 |
Why?
|
| Health Education | 1 | 2004 | 110 | 0.050 |
Why?
|
| Skin Ulcer | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cellulitis | 1 | 2003 | 2 | 0.050 |
Why?
|
| Abscess | 1 | 2003 | 6 | 0.050 |
Why?
|
| Utilization Review | 1 | 2003 | 48 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2003 | 43 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 204 | 0.050 |
Why?
|
| Medical History Taking | 2 | 1994 | 35 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 76 | 0.050 |
Why?
|
| Anthropology, Cultural | 1 | 2002 | 7 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2002 | 17 | 0.050 |
Why?
|
| Burnout, Professional | 1 | 2002 | 14 | 0.050 |
Why?
|
| Patient Care | 1 | 2002 | 35 | 0.050 |
Why?
|
| Poverty | 1 | 2003 | 166 | 0.050 |
Why?
|
| fas Receptor | 1 | 2001 | 1 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 2 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 8 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 4 | 0.050 |
Why?
|
| Monocytes | 1 | 2001 | 5 | 0.050 |
Why?
|
| Homeostasis | 1 | 2001 | 11 | 0.050 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2002 | 74 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 50 | 0.050 |
Why?
|
| Apoptosis | 1 | 2001 | 10 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2001 | 30 | 0.050 |
Why?
|
| Analgesics | 1 | 2021 | 27 | 0.050 |
Why?
|
| Patients | 1 | 2001 | 35 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 4 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 280 | 0.040 |
Why?
|
| Ohio | 1 | 2020 | 23 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2000 | 124 | 0.040 |
Why?
|
| Virginia | 1 | 1998 | 5 | 0.040 |
Why?
|
| Genital Neoplasms, Female | 1 | 1998 | 2 | 0.040 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 1998 | 6 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 22 | 0.040 |
Why?
|
| Prescription Drug Misuse | 1 | 2018 | 9 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 60 | 0.040 |
Why?
|
| Liver Diseases | 1 | 1998 | 23 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1998 | 43 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 49 | 0.040 |
Why?
|
| Self-Assessment | 1 | 1998 | 14 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 1998 | 69 | 0.040 |
Why?
|
| Glutamine | 1 | 2017 | 2 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2017 | 2 | 0.040 |
Why?
|
| Anhedonia | 1 | 2017 | 5 | 0.040 |
Why?
|
| Bronchial Spasm | 1 | 1997 | 1 | 0.040 |
Why?
|
| Health Resources | 1 | 1997 | 36 | 0.040 |
Why?
|
| Cocaine | 1 | 1997 | 6 | 0.040 |
Why?
|
| Urban Health | 1 | 1997 | 38 | 0.030 |
Why?
|
| Social Stigma | 1 | 2017 | 16 | 0.030 |
Why?
|
| Global Health | 1 | 2017 | 31 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 1997 | 12 | 0.030 |
Why?
|
| Brain | 1 | 2017 | 47 | 0.030 |
Why?
|
| Heart Rate | 1 | 1997 | 41 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 115 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2008 | 301 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1998 | 203 | 0.030 |
Why?
|
| Idaho | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 8 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 348 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 80 | 0.030 |
Why?
|
| Primary Prevention | 1 | 1995 | 70 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2016 | 147 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2013 | 33 | 0.030 |
Why?
|
| Tidal Volume | 1 | 2013 | 1 | 0.030 |
Why?
|
| Propensity Score | 1 | 2013 | 85 | 0.030 |
Why?
|
| Alcoholics Anonymous | 1 | 1992 | 14 | 0.020 |
Why?
|
| Temperance | 1 | 1992 | 24 | 0.020 |
Why?
|
| Binomial Distribution | 1 | 2011 | 2 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 189 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 246 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 1991 | 127 | 0.020 |
Why?
|
| Homeless Persons | 1 | 2008 | 25 | 0.020 |
Why?
|
| Urban Population | 1 | 2008 | 114 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2008 | 105 | 0.020 |
Why?
|
| Prisoners | 1 | 2008 | 54 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 90 | 0.020 |
Why?
|
| Fibromyalgia | 1 | 2006 | 4 | 0.020 |
Why?
|
| Syndrome | 1 | 2006 | 29 | 0.020 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 7 | 0.020 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2004 | 7 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 2004 | 46 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 216 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2004 | 73 | 0.010 |
Why?
|
| Cause of Death | 1 | 2004 | 181 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2002 | 20 | 0.010 |
Why?
|
| Chromones | 1 | 2001 | 1 | 0.010 |
Why?
|
| Caspases | 1 | 2001 | 1 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2001 | 1 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2001 | 1 | 0.010 |
Why?
|
| Antibodies | 1 | 2001 | 2 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 6 | 0.010 |
Why?
|
| Morpholines | 1 | 2001 | 3 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 7 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2001 | 13 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 12 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 7 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 2 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 27 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 72 | 0.010 |
Why?
|
| Animals | 1 | 2001 | 262 | 0.010 |
Why?
|
| Drug Industry | 1 | 2000 | 4 | 0.010 |
Why?
|
| Drug Costs | 1 | 2000 | 34 | 0.010 |
Why?
|
| Advertising as Topic | 1 | 2000 | 23 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 2000 | 20 | 0.010 |
Why?
|
| New York City | 1 | 1997 | 21 | 0.010 |
Why?
|
| Recurrence | 1 | 1997 | 189 | 0.010 |
Why?
|
| Parents | 1 | 1991 | 295 | 0.000 |
Why?
|